DLA Piper’s Israel-related transactions in 2013 exceed aggregate value of $2bn
DLA Piper advised on more than 20 significant inbound and outbound US transactions that closed last year on behalf of Israeli institutional investors and companies, as well as foreign investors and acquirers, with an aggregate value of more than $2bn (£1.2bn).
Demonstrating the firm’s strong real estate, mergers and acquisitions, private equity and venture capital capabilities, coupled with its physical presence and active engagement in the Israeli market, the deals included:
- Prolor Biotech’s $480m sale to Opko Health
- Alony Hetz Properties’ $330m investment deal with Carr Properties
- Harel Insurance Company and Menora Mivtachim Insurance’s joint $277m acquisition of the 57-storey IDS Center in Minneapolis, partnering with Beacon Investment Properties
- Fosun Pharma Group’s $240m acquisition of Alma Lasers, an Israel-based manufacturer of lasers used in cosmetic surgery
- Harel Insurance Company’s joint $187m acquisition of a 10-storey office building on London’s Fleet Street, partnering with Ares Commercial Real Estate Group
The increase in Israeli-US transaction volume follows DLA Piper’s decision to develop a global Israel practice nearly five years ago, led by partner Jeremy Lustman, who oversees a significant number of key relationships.
The firm currently represents more than 100 clients in Israel and has advised Israeli companies and investors across more than 35 different jurisdictions.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
DLA Piper has released the 29 September 2014 issue of its Health Alert, which focuses on judgments, legislation and reports in the health sector.
Facing the looming economic threat: third parties retain the right to intervene in threatened industrial action
Third parties have retained the recently acquired right to intervene to protect their interests in the face of threatened industrial action.
Analysis from The Lawyer
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.
A new breed of lawyer is smoothing the path for companies entering emerging or unstable jurisdictions